NCT01609075View on ClinicalTrials.gov

An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer in Italy (BEWARE)

CompletedOBSERVATIONAL
Enrollment

437

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Colorectal Cancer
Trial Locations (72)

10043

Orbassano

10126

Turin

10153

Turin

12100

Cuneo

13875

Ponderano (BI)

16132

Genoa

19100

La Spezia

20059

Vimercate

20099

Milan

20142

Milan

20900

Monza

21047

Saronno

21100

Varese

22020

S. Fermo Della Battaglia (CO)

23900

Lecco

24121

Bergamo

25124

Brescia

26100

Cremona

27100

Pavia

28100

Novara

30035

Mirano

31100

Treviso

33170

Pordenone

35042

Este

Este (PD)

35128

Padua

36075

Montecchio Maggiore

40026

Imola (BO)

41100

Modena

43100

Parma

44124

Cona (Ferrara)

45100

Rovigo

53100

Siena

55043

Lido di Camaiore

56025

Pontedera

57100

Livorno

58100

Grosseto

61032

Fano

62100

Macerata

63023

Fermo

64100

Teramo

67010

L’Aquila

70013

Castellana Grotte (BA)

71013

San Giovanni Rotondo

71100

Foggia

72100

Brindisi

73100

Lecce

80100

Napoli

80131

Napoli

82100

Benevento

84016

Pagani ( Sa)

85028

Rionero in Vulture

87100

Cosenza

88046

Lamezia Terme (CZ)

89100

Reggio Calabria

90015

Cefalù

90100

Palermo

95123

Catania

98030

Taormina

98125

Messina

98158

Messina

00041

Albano Laziale

00128

Rome

00157

Rome

00185

Rome

00189

Rome

03039

Sora

01100

Viterbo

Unknown

Savona

09121

Cagliari

07100

Sassari

06156

Perugia

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01609075 - An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer in Italy (BEWARE) | Biotech Hunter | Biotech Hunter